Spore-forming probiotics for functional dyspepsia
- PMID: 34358485
- DOI: 10.1016/S2468-1253(21)00260-0
Spore-forming probiotics for functional dyspepsia
Conflict of interest statement
SK has received grant or research support from the National Health and Medical Research Council (Ideas Grant and Centre for Research Excellence); research contracts from Viscera Labs and Microba Life Science; and has worked as a consultant or on advisory boards for Gossamer Bio (scientific advisory board), Anatara Lifescience (scientific advisory board), and Microba Life Science (consultancy). GLB and ECH declare no competing interests.
Comment on
-
Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial.Lancet Gastroenterol Hepatol. 2021 Oct;6(10):784-792. doi: 10.1016/S2468-1253(21)00226-0. Epub 2021 Aug 3. Lancet Gastroenterol Hepatol. 2021. PMID: 34358486 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
